The Mater VTE working group will host the 3rd annual international Thrombosis conference in Dublin in September

The event will bring world experts in the field of Thrombosis to Dublin.  Venous thromboembolism (VTE) is a leading cause of death in cancer patients, is the third highest cardiovascular killer (after heart attack and stroke) and is the top direct cause of maternal death in the UK & Ireland.  In a recent report VTE was responsible for approximately half a million deaths in Europe in one year.

In addition, these annual conferences have been supported and endorsed by Science Foundation Ireland, German Society for Vascular Disease (DGA,) German society for Haemostasis and Thrombosis Research (GTH), and the European Pulmonary Hypertension Association (PHA Europe).  Our stellar international and national faculty will be joined by registrants from around the globe.

In 2015 Minister for Health, spoke of the massive worldwide burden imposed by VTE and described it as a leading cause of cardiovascular death in the western world, affecting approximately 1.5 million Europeans every year.  Minister Varadkar highlighted data indicating that VTE remains a major (potentially preventable) cause of death and morbidity in pregnant and postpartum women worldwide and was identified as the top direct cause of maternal death in the UK and Ireland.  Lectures delivered by Prof Beverley Hunt (London), Prof Stavros Konstantinide (Greece) and Dr Rachel Rosovsky (Boston) among others at the 2016 event galvanized action on VTE prevention, which led to the formation of a national VTE Clinical group, VTE Ireland.

The ultrasound workshop with hands on training and short lectures in bedside diagnosis of DVT and PE including ECHO will be expanded to two days this year as a pre-conference event.  Registration and programme details for both the conference and ultrasound training will shortly be available on the VTE conference website

Mandatory assessment with appropriate thromboprophylaxis could prevent 1,900 VTE deaths a year


Dr Susan O’Shea

In an interview with the Irish Medical Times, Dr Susan O’Shea, Consultant Haemotologist in Cork University Hospital, said there had been an 8 per cent reduction in mortality from hospital-associated VTE in the UK since 2010, which was directly related to the introduction of national VTE guidelines there. Dr O’Shea suggested that the same benefit could be seen here in Ireland.

You can read the full article over on the IMT website

I thought I had been bitten by a mosquito – it was a blood clot…


Shay Kearney

The Irish Independent has just published an article interviewing Businessman Shay Kearney about his experience of a DVT. Our own Dr Tomás Breslin is also interviewed.

Currently, in Ireland there are no national guidelines for the administration of this medication to hospital patients. In the UK, they introduced national guidelines like this in 2010 and they estimate this reduced deaths from hospital-related clots by 8%

Dr Tomás Breslin, Consultant in Emergency Medicine, Mater Misericordiae University Hospital


Dr Tomás Breslin

You can read the full article over at the Irish Independent Website